Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
180.01
0.00 (0.00%)
Oct 22, 2026, 9:35 AM EDT - Market open
Repligen Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Repligen stock has a consensus rating of "Buy" and an average price target of $197.95. The average 1-year stock price forecast is 9.97% higher than the current stock price, while the lowest is $145 (-19.45%) and the highest is $235 (+30.55%).
Price Target: $197.95 (+9.97%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Repligen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 15 | 15 | 15 | 15 |
| Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Hold | 4 | 4 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $145 → $180 | Hold | Maintains | $145 → $180 | -0.01% | Oct 19, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $175 → $200 | Buy | Maintains | $175 → $200 | +11.10% | Oct 17, 2026 |
| Barclays | Barclays | Buy Maintains $175 → $225 | Buy | Maintains | $175 → $225 | +24.99% | Oct 7, 2026 |
| UBS | UBS | Buy Maintains $225 | Buy | Maintains | $225 | +24.99% | Sep 29, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 25, 2026 |
Financial Forecast
Revenue This Year
833.30M
from 738.26M
Increased by 12.87%
Revenue Next Year
1.08B
from 833.30M
Increased by 29.67%
EPS This Year
2.06
from 1.71
Increased by 20.74%
EPS Next Year
2.67
from 2.06
Increased by 29.31%
EPS and Forward PE are based on non-GAAP adjusted numbers.